HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.108.056366v1 50/4/582    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Liu, X. Articles by Hnatowich, D. J. Search for Related Content PubMed PubMed Citation Articles by Liu, X. Articles by Hnatowich, D. J.

Auger Radiation–Induced, Antisense-Mediated Cytotoxicity of Tumor Cells Using a 3-Component Streptavidin-Delivery Nanoparticle with ¹¹¹In

¹ Division of Nuclear Medicine, Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts; ² Department of Radiology, Keio University School of Medicine, Tokyo, Japan; and ³ Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts

Correspondence: For correspondence or reprints contact: Donald J. Hnatowich, Division of Nuclear Medicine, Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655. E-mail: donald.hnatowich{at}umassmed.edu

When antisense oligomers are intracellular, they migrate to and are retained in the nucleus of tumor cells and therefore may be used to carry Auger electron–emitting radionuclides such as ¹¹¹In for effective tumor radiotherapy. Methods: Our nanoparticle consists of streptavidin that links 3 biotinylated components: the antiHer2 antibody trastuzumab (to improve pharmacokinetics), the tat peptide (to improve cell membrane transport), and the ¹¹¹In-labeled antiRI messenger RNA antisense morpholino (MORF) oligomer. Results: As evidence of unimpaired function, tumor cell and nuclear accumulations were orders of magnitude higher after incubation with ^99mTc-MORF/tat/trastuzumab than after incubation with free ^99mTc-MORF and significantly higher with the antisense than with the sense MORF. In mice, tumor and normal-tissue accumulations of the ^99mTc-MORF/tat/trastuzumab nanoparticle were comparable to those of free ^99mTc-trastuzumab, confirming the improved pharmacokinetics due to the trastuzumab component. Although kidneys, liver, and other normal tissues also accumulated the nanoparticle, immunohistochemical evaluation of tissue sections in mice receiving the Cy3-MORF/tat/trastuzumab nanoparticle showed evidence of nuclear accumulation only in tumor tissue. In a dose escalation study, as measured by the surviving fraction, the nanoparticle significantly increased the kill of SK-BR-3 breast cancer Her2+/RI+ cells, compared with all controls. Conclusion: Significant radiation-induced antisense-mediated cytotoxicity of tumor cells in vitro was achieved using an Auger electron–emitting antisense MORF oligomer administered as a member of a 3-component streptavidin-delivery nanoparticle.

Key Words: antisense oligomer • delivery nanoparticle • radiotherapy • Auger electron–emitting radionuclide • streptavidin

COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2009 50: 11A-12A. [Full Text]